These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8095169)
1. C-erbB-2 protein in the sera of breast cancer patients. Narita T; Funahashi H; Satoh Y; Takagi H Breast Cancer Res Treat; 1992; 24(2):97-102. PubMed ID: 8095169 [TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay. Narita T; Funahashi H; Satoh Y; Imai T; Takagi H Jpn J Clin Oncol; 1994 Apr; 24(2):74-8. PubMed ID: 7908994 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of serum c-erbB-2 protein in breast cancer patients. Willsher PC; Beaver J; Pinder S; Bell JA; Ellis IO; Blamey RW; Robertson JF Breast Cancer Res Treat; 1996; 40(3):251-5. PubMed ID: 8883967 [TBL] [Abstract][Full Text] [Related]
4. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. Travis A; Pinder SE; Robertson JF; Bell JA; Wencyk P; Gullick WJ; Nicholson RI; Poller DN; Blamey RW; Elston CW; Ellis IO Br J Cancer; 1996 Jul; 74(2):229-33. PubMed ID: 8688326 [TBL] [Abstract][Full Text] [Related]
5. Serum c-erbB-2 protein is a useful marker for monitoring tumor recurrence of the breast. Imoto S; Wada N; Hasebe T; Ochiai A; Kitoh T Int J Cancer; 2007 Jan; 120(2):357-61. PubMed ID: 17044019 [TBL] [Abstract][Full Text] [Related]
6. Combined measurement of the c-erbB-2 protein in breast carcinoma tissues and sera is useful as a sensitive tumor marker for monitoring tumor relapse. Sugano K; Ushiama M; Fukutomi T; Tsuda H; Kitoh T; Ohkura H Int J Cancer; 2000 Jul; 89(4):329-36. PubMed ID: 10956406 [TBL] [Abstract][Full Text] [Related]
7. C-erbB-2 oncoprotein in the sera and tissue of patients with breast cancer. Utility in prognosis. Molina R; Jo J; Filella X; Zanon G; Pahisa J; Muñoz M; Farrus B; Latre ML; Gimenez N; Hage M; Estape J; Ballesta AM Anticancer Res; 1996; 16(4B):2295-300. PubMed ID: 8694559 [TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapy. Classen S; Kopp R; Possinger K; Weidenhagen R; Eiermann W; Wilmanns W Tumour Biol; 2002; 23(2):70-5. PubMed ID: 12065844 [TBL] [Abstract][Full Text] [Related]
9. Serum c-erbB-2 in breast cancer patients. Watanabe N; Miyamoto M; Tokuda Y; Kubota M; Ando Y; Tajima T; Mitomi T Acta Oncol; 1994; 33(8):901-4. PubMed ID: 7818922 [TBL] [Abstract][Full Text] [Related]
10. Tissue and serum c-erbB-2 and tissue EGFR in breast carcinoma: three years follow-up. Mansour OA; Zekri AR; Harvey J; Teramoto Y; el-Ahmady O Anticancer Res; 1997; 17(4B):3101-6. PubMed ID: 9329611 [TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of serum ErbB-2 protein using enzyme immuno assay (ErbB-2 EIA [Nichirei])]. Sugano K; Kawai T; Ishii M; Koyama H; Kitajima M; Kasumi F; Demura R; Nakayama T; Okabe H; Mori S Gan To Kagaku Ryoho; 1994 Jul; 21(8):1255-62. PubMed ID: 7913313 [TBL] [Abstract][Full Text] [Related]
12. Serum c-erbB-2 protein in breast cancer patients. Chearskul S; Sinlarat P; Bhothisuwan K; Churintrapun M; Ornrhebroi S; Klinsala N; Sungkabunchoo S J Med Assoc Thai; 2000 Aug; 83(8):886-93. PubMed ID: 10998842 [TBL] [Abstract][Full Text] [Related]
13. Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer. Isola JJ; Holli K; Oksa H; Teramoto Y; Kallioniemi OP Cancer; 1994 Feb; 73(3):652-8. PubMed ID: 7905363 [TBL] [Abstract][Full Text] [Related]
14. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients. Leitzel K; Teramoto Y; Sampson E; Mauceri J; Langton BC; Demers L; Podczaski E; Harvey H; Shambaugh S; Volas G J Clin Oncol; 1992 Sep; 10(9):1436-43. PubMed ID: 1355522 [TBL] [Abstract][Full Text] [Related]
15. Dual colour flow cytometry of p53 and c-erbB-2 expression related to DNA aneuploidy in primary and metastatic breast cancer. Clark JS; George WD; Campbell AM Cancer Lett; 1992 Oct; 66(3):193-200. PubMed ID: 1360329 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients. Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997 [TBL] [Abstract][Full Text] [Related]
17. C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients. Molina R; Jo J; Filella X; Zanón G; Farrus B; Muñoz M; Latre ML; Pahisa J; Velasco M; Fernandez P; Estapé J; Ballesta AM Anticancer Res; 1999; 19(4A):2551-5. PubMed ID: 10470193 [TBL] [Abstract][Full Text] [Related]
18. Serum c-erB-2 levels in monitoring of operable breast cancer patients. Imoto S; Kitoh T; Hasebe T Jpn J Clin Oncol; 1999 Jul; 29(7):336-9. PubMed ID: 10470658 [TBL] [Abstract][Full Text] [Related]
19. Significance of immunohistochemically detected c-erbB-2 protein expression in stage III breast cancer, with reference to nuclear deformity, DNA content and prognosis. Tamura G; Maesawa C; Mikawa S; Satodate R Jpn J Clin Oncol; 1991 Aug; 21(4):264-7. PubMed ID: 1682519 [TBL] [Abstract][Full Text] [Related]
20. Determination of cytosol c-erbB-2 protein in breast cancer by sandwich enzyme immunoassay. Imoto S; Ohkura H; Sugano K; Sasaki Y; Ito K; Igarashi T; Ohtsu T; Fujii H; Minami H; Hasebe T; Mukai K Jpn J Clin Oncol; 1998 Feb; 28(2):92-6. PubMed ID: 9544822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]